nodes	percent_of_prediction	percent_of_DWPC	metapath
Rufinamide—GRM5—epilepsy syndrome	0.0756	0.198	CbGaD
Rufinamide—SCN8A—epilepsy syndrome	0.0692	0.181	CbGaD
Rufinamide—SCN9A—epilepsy syndrome	0.0559	0.146	CbGaD
Rufinamide—SCN3A—epilepsy syndrome	0.0535	0.14	CbGaD
Rufinamide—SCN4A—epilepsy syndrome	0.0514	0.134	CbGaD
Rufinamide—SCN1A—epilepsy syndrome	0.0376	0.0981	CbGaD
Rufinamide—SCN2A—epilepsy syndrome	0.0331	0.0865	CbGaD
Rufinamide—SCN8A—Lamotrigine—epilepsy syndrome	0.0223	0.0546	CbGbCtD
Rufinamide—SCN8A—Phenytoin—epilepsy syndrome	0.0172	0.0421	CbGbCtD
Rufinamide—SCN11A—Zonisamide—epilepsy syndrome	0.017	0.0415	CbGbCtD
Rufinamide—SCN9A—Lamotrigine—epilepsy syndrome	0.0146	0.0357	CbGbCtD
Rufinamide—SCN9A—Lacosamide—epilepsy syndrome	0.0146	0.0357	CbGbCtD
Rufinamide—SCN3A—Lacosamide—epilepsy syndrome	0.0133	0.0326	CbGbCtD
Rufinamide—SCN3A—Lamotrigine—epilepsy syndrome	0.0133	0.0326	CbGbCtD
Rufinamide—SCN9A—Carbamazepine—epilepsy syndrome	0.0126	0.0307	CbGbCtD
Rufinamide—SCN4A—Lamotrigine—epilepsy syndrome	0.0123	0.0301	CbGbCtD
Rufinamide—SCN2A—Lamotrigine—epilepsy syndrome	0.0123	0.0301	CbGbCtD
Rufinamide—SCN10A—Lacosamide—epilepsy syndrome	0.0115	0.028	CbGbCtD
Rufinamide—SCN10A—Lamotrigine—epilepsy syndrome	0.0115	0.028	CbGbCtD
Rufinamide—SCN1A—Lamotrigine—epilepsy syndrome	0.0115	0.028	CbGbCtD
Rufinamide—SCN9A—Phenytoin—epilepsy syndrome	0.0113	0.0275	CbGbCtD
Rufinamide—SCN5A—Oxcarbazepine—epilepsy syndrome	0.0107	0.0263	CbGbCtD
Rufinamide—SCN4A—Carbamazepine—epilepsy syndrome	0.0106	0.0259	CbGbCtD
Rufinamide—SCN3A—Phenytoin—epilepsy syndrome	0.0103	0.0252	CbGbCtD
Rufinamide—SCN4A—Phenytoin—epilepsy syndrome	0.00951	0.0233	CbGbCtD
Rufinamide—SCN2A—Phenytoin—epilepsy syndrome	0.00951	0.0233	CbGbCtD
Rufinamide—SCN5A—Fosphenytoin—epilepsy syndrome	0.00938	0.0229	CbGbCtD
Rufinamide—SCN9A—Zonisamide—epilepsy syndrome	0.00929	0.0227	CbGbCtD
Rufinamide—SCN2A—Propofol—epilepsy syndrome	0.00887	0.0217	CbGbCtD
Rufinamide—SCN4A—Propofol—epilepsy syndrome	0.00887	0.0217	CbGbCtD
Rufinamide—SCN1A—Phenytoin—epilepsy syndrome	0.00884	0.0216	CbGbCtD
Rufinamide—SCN3A—Zonisamide—epilepsy syndrome	0.0085	0.0208	CbGbCtD
Rufinamide—SCN2A—Zonisamide—epilepsy syndrome	0.00784	0.0192	CbGbCtD
Rufinamide—SCN4A—Zonisamide—epilepsy syndrome	0.00784	0.0192	CbGbCtD
Rufinamide—SCN5A—Lamotrigine—epilepsy syndrome	0.00783	0.0192	CbGbCtD
Rufinamide—SCN1A—Zonisamide—epilepsy syndrome	0.00729	0.0178	CbGbCtD
Rufinamide—SCN5A—Carbamazepine—epilepsy syndrome	0.00674	0.0165	CbGbCtD
Rufinamide—ALB—epilepsy syndrome	0.00654	0.0171	CbGaD
Rufinamide—SCN5A—Phenytoin—epilepsy syndrome	0.00605	0.0148	CbGbCtD
Rufinamide—SCN1A—Topiramate—epilepsy syndrome	0.00532	0.013	CbGbCtD
Rufinamide—SCN5A—Zonisamide—epilepsy syndrome	0.00499	0.0122	CbGbCtD
Rufinamide—ALB—Oxcarbazepine—epilepsy syndrome	0.00416	0.0102	CbGbCtD
Rufinamide—CYP2E1—Trimethadione—epilepsy syndrome	0.004	0.00978	CbGbCtD
Rufinamide—CYP2E1—Felbamate—epilepsy syndrome	0.004	0.00978	CbGbCtD
Rufinamide—ALB—Fosphenytoin—epilepsy syndrome	0.00364	0.00889	CbGbCtD
Rufinamide—SCN5A—Topiramate—epilepsy syndrome	0.00363	0.00889	CbGbCtD
Rufinamide—CYP2E1—Clonazepam—epilepsy syndrome	0.0034	0.00832	CbGbCtD
Rufinamide—SCN3A—spinal nerve—epilepsy syndrome	0.00332	0.0886	CbGeAlD
Rufinamide—ALB—Clonazepam—epilepsy syndrome	0.00329	0.00804	CbGbCtD
Rufinamide—GRM5—telencephalic ventricle—epilepsy syndrome	0.00296	0.0789	CbGeAlD
Rufinamide—SCN8A—cerebellar cortex—epilepsy syndrome	0.00286	0.0763	CbGeAlD
Rufinamide—ALB—Phenytoin—epilepsy syndrome	0.00234	0.00573	CbGbCtD
Rufinamide—CYP2E1—Propofol—epilepsy syndrome	0.00226	0.00553	CbGbCtD
Rufinamide—ALB—Propofol—epilepsy syndrome	0.00219	0.00535	CbGbCtD
Rufinamide—CYP2E1—Phenobarbital—epilepsy syndrome	0.00216	0.00528	CbGbCtD
Rufinamide—CYP2E1—Midazolam—epilepsy syndrome	0.00213	0.00521	CbGbCtD
Rufinamide—CYP2E1—Diazepam—epilepsy syndrome	0.00205	0.00501	CbGbCtD
Rufinamide—ALB—Diazepam—epilepsy syndrome	0.00198	0.00484	CbGbCtD
Rufinamide—GRM5—ganglion—epilepsy syndrome	0.00184	0.0491	CbGeAlD
Rufinamide—GRM5—hindbrain—epilepsy syndrome	0.0014	0.0372	CbGeAlD
Rufinamide—SCN11A—ganglion—epilepsy syndrome	0.00137	0.0365	CbGeAlD
Rufinamide—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0013	0.00319	CbGbCtD
Rufinamide—CYP3A4—Felbamate—epilepsy syndrome	0.00121	0.00296	CbGbCtD
Rufinamide—CYP3A4—Trimethadione—epilepsy syndrome	0.00121	0.00296	CbGbCtD
Rufinamide—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00114	0.00279	CbGbCtD
Rufinamide—CYP3A4—Clonazepam—epilepsy syndrome	0.00103	0.00252	CbGbCtD
Rufinamide—CYP3A4—Clobazam—epilepsy syndrome	0.000988	0.00242	CbGbCtD
Rufinamide—CYP3A4—Carbamazepine—epilepsy syndrome	0.000819	0.002	CbGbCtD
Rufinamide—GRM5—brainstem—epilepsy syndrome	0.000801	0.0213	CbGeAlD
Rufinamide—SCN8A—hindbrain—epilepsy syndrome	0.000787	0.021	CbGeAlD
Rufinamide—GRM5—forebrain—epilepsy syndrome	0.000773	0.0206	CbGeAlD
Rufinamide—CYP3A4—Primidone—epilepsy syndrome	0.000764	0.00187	CbGbCtD
Rufinamide—CYP3A4—Phenytoin—epilepsy syndrome	0.000734	0.0018	CbGbCtD
Rufinamide—GRM5—telencephalon—epilepsy syndrome	0.000711	0.0189	CbGeAlD
Rufinamide—SCN10A—ganglion—epilepsy syndrome	0.000694	0.0185	CbGeAlD
Rufinamide—CYP3A4—Propofol—epilepsy syndrome	0.000685	0.00168	CbGbCtD
Rufinamide—CYP3A4—Acetazolamide—epilepsy syndrome	0.000655	0.0016	CbGbCtD
Rufinamide—CYP3A4—Phenobarbital—epilepsy syndrome	0.000655	0.0016	CbGbCtD
Rufinamide—CYP3A4—Midazolam—epilepsy syndrome	0.000645	0.00158	CbGbCtD
Rufinamide—CYP3A4—Diazepam—epilepsy syndrome	0.00062	0.00152	CbGbCtD
Rufinamide—CYP3A4—Zonisamide—epilepsy syndrome	0.000606	0.00148	CbGbCtD
Rufinamide—SCN1A—hindbrain—epilepsy syndrome	0.000595	0.0158	CbGeAlD
Rufinamide—SCN2A—hindbrain—epilepsy syndrome	0.000546	0.0145	CbGeAlD
Rufinamide—GRM5—midbrain—epilepsy syndrome	0.000511	0.0136	CbGeAlD
Rufinamide—GRM5—spinal cord—epilepsy syndrome	0.000498	0.0133	CbGeAlD
Rufinamide—CYP3A4—Valproic Acid—epilepsy syndrome	0.000489	0.0012	CbGbCtD
Rufinamide—SCN8A—brainstem—epilepsy syndrome	0.000451	0.012	CbGeAlD
Rufinamide—GRM5—head—epilepsy syndrome	0.000443	0.0118	CbGeAlD
Rufinamide—CYP3A4—Topiramate—epilepsy syndrome	0.000441	0.00108	CbGbCtD
Rufinamide—SCN8A—forebrain—epilepsy syndrome	0.000435	0.0116	CbGeAlD
Rufinamide—GRM5—nervous system—epilepsy syndrome	0.00042	0.0112	CbGeAlD
Rufinamide—GRM5—central nervous system—epilepsy syndrome	0.000404	0.0108	CbGeAlD
Rufinamide—SCN8A—telencephalon—epilepsy syndrome	0.0004	0.0107	CbGeAlD
Rufinamide—GRM5—cerebellum—epilepsy syndrome	0.000395	0.0105	CbGeAlD
Rufinamide—SCN11A—spinal cord—epilepsy syndrome	0.00037	0.00985	CbGeAlD
Rufinamide—SCN1A—brainstem—epilepsy syndrome	0.000341	0.00908	CbGeAlD
Rufinamide—SCN1A—forebrain—epilepsy syndrome	0.000329	0.00876	CbGeAlD
Rufinamide—SCN11A—head—epilepsy syndrome	0.000329	0.00876	CbGeAlD
Rufinamide—GRM5—brain—epilepsy syndrome	0.000321	0.00855	CbGeAlD
Rufinamide—SCN2A—brainstem—epilepsy syndrome	0.000313	0.00833	CbGeAlD
Rufinamide—SCN11A—nervous system—epilepsy syndrome	0.000312	0.0083	CbGeAlD
Rufinamide—SCN1A—telencephalon—epilepsy syndrome	0.000302	0.00806	CbGeAlD
Rufinamide—SCN2A—forebrain—epilepsy syndrome	0.000302	0.00804	CbGeAlD
Rufinamide—SCN11A—central nervous system—epilepsy syndrome	0.0003	0.00799	CbGeAlD
Rufinamide—SCN10A—forebrain—epilepsy syndrome	0.000291	0.00776	CbGeAlD
Rufinamide—SCN8A—spinal cord—epilepsy syndrome	0.00028	0.00747	CbGeAlD
Rufinamide—SCN7A—head—epilepsy syndrome	0.000279	0.00745	CbGeAlD
Rufinamide—SCN2A—telencephalon—epilepsy syndrome	0.000278	0.0074	CbGeAlD
Rufinamide—SCN10A—telencephalon—epilepsy syndrome	0.000268	0.00713	CbGeAlD
Rufinamide—SCN3A—forebrain—epilepsy syndrome	0.000265	0.00707	CbGeAlD
Rufinamide—SCN9A—midbrain—epilepsy syndrome	0.000252	0.00673	CbGeAlD
Rufinamide—SCN8A—head—epilepsy syndrome	0.000249	0.00664	CbGeAlD
Rufinamide—SCN9A—spinal cord—epilepsy syndrome	0.000246	0.00656	CbGeAlD
Rufinamide—SCN3A—telencephalon—epilepsy syndrome	0.000244	0.0065	CbGeAlD
Rufinamide—SCN11A—brain—epilepsy syndrome	0.000238	0.00635	CbGeAlD
Rufinamide—SCN1A—medulla oblongata—epilepsy syndrome	0.000238	0.00633	CbGeAlD
Rufinamide—SCN8A—nervous system—epilepsy syndrome	0.000236	0.00629	CbGeAlD
Rufinamide—SCN8A—central nervous system—epilepsy syndrome	0.000227	0.00606	CbGeAlD
Rufinamide—SCN8A—cerebellum—epilepsy syndrome	0.000222	0.00592	CbGeAlD
Rufinamide—SCN2A—medulla oblongata—epilepsy syndrome	0.000218	0.00581	CbGeAlD
Rufinamide—SCN1A—midbrain—epilepsy syndrome	0.000217	0.00579	CbGeAlD
Rufinamide—SCN1A—spinal cord—epilepsy syndrome	0.000212	0.00565	CbGeAlD
Rufinamide—SCN7A—brain—epilepsy syndrome	0.000203	0.0054	CbGeAlD
Rufinamide—SCN2A—midbrain—epilepsy syndrome	0.000199	0.00531	CbGeAlD
Rufinamide—SCN4A—head—epilepsy syndrome	0.000195	0.0052	CbGeAlD
Rufinamide—SCN2A—spinal cord—epilepsy syndrome	0.000194	0.00518	CbGeAlD
Rufinamide—SCN3A—medulla oblongata—epilepsy syndrome	0.000192	0.00511	CbGeAlD
Rufinamide—SCN1A—head—epilepsy syndrome	0.000188	0.00502	CbGeAlD
Rufinamide—SCN10A—spinal cord—epilepsy syndrome	0.000188	0.005	CbGeAlD
Rufinamide—SCN4A—nervous system—epilepsy syndrome	0.000185	0.00493	CbGeAlD
Rufinamide—SCN8A—brain—epilepsy syndrome	0.000181	0.00481	CbGeAlD
Rufinamide—SCN1A—nervous system—epilepsy syndrome	0.000179	0.00476	CbGeAlD
Rufinamide—SCN4A—central nervous system—epilepsy syndrome	0.000178	0.00475	CbGeAlD
Rufinamide—SCN3A—midbrain—epilepsy syndrome	0.000175	0.00467	CbGeAlD
Rufinamide—CES1—head—epilepsy syndrome	0.000174	0.00465	CbGeAlD
Rufinamide—SCN2A—head—epilepsy syndrome	0.000173	0.00461	CbGeAlD
Rufinamide—SCN1A—central nervous system—epilepsy syndrome	0.000172	0.00458	CbGeAlD
Rufinamide—SCN3A—spinal cord—epilepsy syndrome	0.000171	0.00455	CbGeAlD
Rufinamide—SCN1A—cerebellum—epilepsy syndrome	0.000168	0.00448	CbGeAlD
Rufinamide—SCN10A—head—epilepsy syndrome	0.000167	0.00444	CbGeAlD
Rufinamide—CES1—nervous system—epilepsy syndrome	0.000165	0.00441	CbGeAlD
Rufinamide—SCN2A—nervous system—epilepsy syndrome	0.000164	0.00437	CbGeAlD
Rufinamide—CES1—central nervous system—epilepsy syndrome	0.000159	0.00424	CbGeAlD
Rufinamide—SCN9A—brain—epilepsy syndrome	0.000159	0.00423	CbGeAlD
Rufinamide—SCN10A—nervous system—epilepsy syndrome	0.000158	0.00421	CbGeAlD
Rufinamide—SCN2A—central nervous system—epilepsy syndrome	0.000158	0.0042	CbGeAlD
Rufinamide—SCN2A—cerebellum—epilepsy syndrome	0.000154	0.00411	CbGeAlD
Rufinamide—SCN10A—central nervous system—epilepsy syndrome	0.000152	0.00405	CbGeAlD
Rufinamide—SCN3A—head—epilepsy syndrome	0.000152	0.00405	CbGeAlD
Rufinamide—SCN5A—head—epilepsy syndrome	0.000151	0.00404	CbGeAlD
Rufinamide—SCN3A—nervous system—epilepsy syndrome	0.000144	0.00384	CbGeAlD
Rufinamide—SCN5A—nervous system—epilepsy syndrome	0.000144	0.00383	CbGeAlD
Rufinamide—SCN4A—brain—epilepsy syndrome	0.000142	0.00377	CbGeAlD
Rufinamide—SCN3A—central nervous system—epilepsy syndrome	0.000139	0.00369	CbGeAlD
Rufinamide—SCN5A—central nervous system—epilepsy syndrome	0.000138	0.00368	CbGeAlD
Rufinamide—SCN1A—brain—epilepsy syndrome	0.000136	0.00364	CbGeAlD
Rufinamide—SCN3A—cerebellum—epilepsy syndrome	0.000136	0.00361	CbGeAlD
Rufinamide—CES1—brain—epilepsy syndrome	0.000126	0.00337	CbGeAlD
Rufinamide—SCN2A—brain—epilepsy syndrome	0.000125	0.00334	CbGeAlD
Rufinamide—SCN10A—brain—epilepsy syndrome	0.000121	0.00322	CbGeAlD
Rufinamide—CYP2E1—telencephalon—epilepsy syndrome	0.000115	0.00307	CbGeAlD
Rufinamide—SCN3A—brain—epilepsy syndrome	0.00011	0.00293	CbGeAlD
Rufinamide—SCN5A—brain—epilepsy syndrome	0.00011	0.00292	CbGeAlD
Rufinamide—CYP2E1—medulla oblongata—epilepsy syndrome	9.05e-05	0.00241	CbGeAlD
Rufinamide—ALB—brain—epilepsy syndrome	8.79e-05	0.00234	CbGeAlD
Rufinamide—CYP2E1—spinal cord—epilepsy syndrome	8.07e-05	0.00215	CbGeAlD
Rufinamide—CYP2E1—head—epilepsy syndrome	7.17e-05	0.00191	CbGeAlD
Rufinamide—CYP2E1—nervous system—epilepsy syndrome	6.8e-05	0.00181	CbGeAlD
Rufinamide—CYP2E1—central nervous system—epilepsy syndrome	6.55e-05	0.00174	CbGeAlD
Rufinamide—CYP2E1—cerebellum—epilepsy syndrome	6.4e-05	0.00171	CbGeAlD
Rufinamide—CYP3A4—nervous system—epilepsy syndrome	5.47e-05	0.00146	CbGeAlD
Rufinamide—CYP3A4—central nervous system—epilepsy syndrome	5.27e-05	0.0014	CbGeAlD
Rufinamide—CYP2E1—brain—epilepsy syndrome	5.2e-05	0.00139	CbGeAlD
Rufinamide—Dizziness—Midazolam—epilepsy syndrome	4.08e-05	0.00044	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	4.08e-05	0.00044	CcSEcCtD
Rufinamide—Fatigue—Lamotrigine—epilepsy syndrome	4.07e-05	0.000439	CcSEcCtD
Rufinamide—Cardiac disorder—Gabapentin—epilepsy syndrome	4.06e-05	0.000438	CcSEcCtD
Rufinamide—Pruritus—Vigabatrin—epilepsy syndrome	4.05e-05	0.000437	CcSEcCtD
Rufinamide—Asthenia—Diazepam—epilepsy syndrome	4.05e-05	0.000437	CcSEcCtD
Rufinamide—Constipation—Lamotrigine—epilepsy syndrome	4.04e-05	0.000435	CcSEcCtD
Rufinamide—Nausea—Acetazolamide—epilepsy syndrome	4.03e-05	0.000435	CcSEcCtD
Rufinamide—Dizziness—Levetiracetam—epilepsy syndrome	4.03e-05	0.000434	CcSEcCtD
Rufinamide—Diarrhoea—Fosphenytoin—epilepsy syndrome	4.02e-05	0.000434	CcSEcCtD
Rufinamide—Back pain—Pregabalin—epilepsy syndrome	4.02e-05	0.000433	CcSEcCtD
Rufinamide—Vomiting—Propofol—epilepsy syndrome	4.01e-05	0.000432	CcSEcCtD
Rufinamide—Pruritus—Diazepam—epilepsy syndrome	3.99e-05	0.000431	CcSEcCtD
Rufinamide—Rash—Propofol—epilepsy syndrome	3.98e-05	0.000429	CcSEcCtD
Rufinamide—Dermatitis—Propofol—epilepsy syndrome	3.97e-05	0.000428	CcSEcCtD
Rufinamide—Immune system disorder—Gabapentin—epilepsy syndrome	3.95e-05	0.000426	CcSEcCtD
Rufinamide—Headache—Propofol—epilepsy syndrome	3.95e-05	0.000426	CcSEcCtD
Rufinamide—Mediastinal disorder—Gabapentin—epilepsy syndrome	3.95e-05	0.000425	CcSEcCtD
Rufinamide—Hypersensitivity—Zonisamide—epilepsy syndrome	3.94e-05	0.000425	CcSEcCtD
Rufinamide—Vomiting—Midazolam—epilepsy syndrome	3.92e-05	0.000423	CcSEcCtD
Rufinamide—Diarrhoea—Vigabatrin—epilepsy syndrome	3.92e-05	0.000423	CcSEcCtD
Rufinamide—Asthenia—Felbamate—epilepsy syndrome	3.92e-05	0.000423	CcSEcCtD
Rufinamide—Vision blurred—Pregabalin—epilepsy syndrome	3.92e-05	0.000422	CcSEcCtD
Rufinamide—Haematuria—Topiramate—epilepsy syndrome	3.91e-05	0.000422	CcSEcCtD
Rufinamide—Anxiety—Valproic Acid—epilepsy syndrome	3.9e-05	0.000421	CcSEcCtD
Rufinamide—Tremor—Pregabalin—epilepsy syndrome	3.89e-05	0.00042	CcSEcCtD
Rufinamide—Rash—Midazolam—epilepsy syndrome	3.89e-05	0.000419	CcSEcCtD
Rufinamide—Dizziness—Fosphenytoin—epilepsy syndrome	3.89e-05	0.000419	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	3.89e-05	0.000419	CcSEcCtD
Rufinamide—Dermatitis—Midazolam—epilepsy syndrome	3.89e-05	0.000419	CcSEcCtD
Rufinamide—Vomiting—Levetiracetam—epilepsy syndrome	3.87e-05	0.000418	CcSEcCtD
Rufinamide—Epistaxis—Topiramate—epilepsy syndrome	3.87e-05	0.000417	CcSEcCtD
Rufinamide—Headache—Midazolam—epilepsy syndrome	3.86e-05	0.000417	CcSEcCtD
Rufinamide—Pruritus—Felbamate—epilepsy syndrome	3.86e-05	0.000417	CcSEcCtD
Rufinamide—Diarrhoea—Diazepam—epilepsy syndrome	3.86e-05	0.000416	CcSEcCtD
Rufinamide—Sinusitis—Topiramate—epilepsy syndrome	3.85e-05	0.000415	CcSEcCtD
Rufinamide—Rash—Levetiracetam—epilepsy syndrome	3.84e-05	0.000414	CcSEcCtD
Rufinamide—Anaemia—Pregabalin—epilepsy syndrome	3.84e-05	0.000414	CcSEcCtD
Rufinamide—Dermatitis—Levetiracetam—epilepsy syndrome	3.84e-05	0.000414	CcSEcCtD
Rufinamide—Asthenia—Zonisamide—epilepsy syndrome	3.84e-05	0.000414	CcSEcCtD
Rufinamide—Mental disorder—Gabapentin—epilepsy syndrome	3.83e-05	0.000414	CcSEcCtD
Rufinamide—Agitation—Pregabalin—epilepsy syndrome	3.82e-05	0.000412	CcSEcCtD
Rufinamide—Headache—Levetiracetam—epilepsy syndrome	3.82e-05	0.000412	CcSEcCtD
Rufinamide—Malnutrition—Gabapentin—epilepsy syndrome	3.81e-05	0.000411	CcSEcCtD
Rufinamide—Hypersensitivity—Clonazepam—epilepsy syndrome	3.8e-05	0.000409	CcSEcCtD
Rufinamide—Dizziness—Vigabatrin—epilepsy syndrome	3.79e-05	0.000409	CcSEcCtD
Rufinamide—Pruritus—Zonisamide—epilepsy syndrome	3.78e-05	0.000408	CcSEcCtD
Rufinamide—Hypersensitivity—Phenytoin—epilepsy syndrome	3.77e-05	0.000407	CcSEcCtD
Rufinamide—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	3.75e-05	0.000404	CcSEcCtD
Rufinamide—Nausea—Propofol—epilepsy syndrome	3.75e-05	0.000404	CcSEcCtD
Rufinamide—Vomiting—Fosphenytoin—epilepsy syndrome	3.74e-05	0.000403	CcSEcCtD
Rufinamide—Diarrhoea—Felbamate—epilepsy syndrome	3.74e-05	0.000403	CcSEcCtD
Rufinamide—Vertigo—Pregabalin—epilepsy syndrome	3.73e-05	0.000403	CcSEcCtD
Rufinamide—Dizziness—Diazepam—epilepsy syndrome	3.73e-05	0.000402	CcSEcCtD
Rufinamide—Infection—Valproic Acid—epilepsy syndrome	3.73e-05	0.000402	CcSEcCtD
Rufinamide—Leukopenia—Pregabalin—epilepsy syndrome	3.72e-05	0.000401	CcSEcCtD
Rufinamide—Rash—Fosphenytoin—epilepsy syndrome	3.71e-05	0.0004	CcSEcCtD
Rufinamide—Dermatitis—Fosphenytoin—epilepsy syndrome	3.7e-05	0.000399	CcSEcCtD
Rufinamide—Asthenia—Clonazepam—epilepsy syndrome	3.7e-05	0.000399	CcSEcCtD
Rufinamide—Rhinitis—Topiramate—epilepsy syndrome	3.69e-05	0.000398	CcSEcCtD
Rufinamide—Back pain—Gabapentin—epilepsy syndrome	3.69e-05	0.000397	CcSEcCtD
Rufinamide—Headache—Fosphenytoin—epilepsy syndrome	3.68e-05	0.000397	CcSEcCtD
Rufinamide—Nervous system disorder—Valproic Acid—epilepsy syndrome	3.68e-05	0.000397	CcSEcCtD
Rufinamide—Thrombocytopenia—Valproic Acid—epilepsy syndrome	3.67e-05	0.000396	CcSEcCtD
Rufinamide—Asthenia—Phenytoin—epilepsy syndrome	3.67e-05	0.000396	CcSEcCtD
Rufinamide—Nausea—Midazolam—epilepsy syndrome	3.66e-05	0.000395	CcSEcCtD
Rufinamide—Diarrhoea—Zonisamide—epilepsy syndrome	3.66e-05	0.000394	CcSEcCtD
Rufinamide—Asthenia—Oxcarbazepine—epilepsy syndrome	3.65e-05	0.000394	CcSEcCtD
Rufinamide—Pruritus—Clonazepam—epilepsy syndrome	3.64e-05	0.000393	CcSEcCtD
Rufinamide—Vomiting—Vigabatrin—epilepsy syndrome	3.64e-05	0.000393	CcSEcCtD
Rufinamide—Skin disorder—Valproic Acid—epilepsy syndrome	3.64e-05	0.000393	CcSEcCtD
Rufinamide—Urinary tract disorder—Topiramate—epilepsy syndrome	3.64e-05	0.000392	CcSEcCtD
Rufinamide—Pruritus—Phenytoin—epilepsy syndrome	3.62e-05	0.00039	CcSEcCtD
Rufinamide—Nausea—Levetiracetam—epilepsy syndrome	3.62e-05	0.00039	CcSEcCtD
Rufinamide—Rash—Vigabatrin—epilepsy syndrome	3.61e-05	0.00039	CcSEcCtD
Rufinamide—Dizziness—Felbamate—epilepsy syndrome	3.61e-05	0.000389	CcSEcCtD
Rufinamide—Dermatitis—Vigabatrin—epilepsy syndrome	3.61e-05	0.000389	CcSEcCtD
Rufinamide—Urethral disorder—Topiramate—epilepsy syndrome	3.61e-05	0.000389	CcSEcCtD
Rufinamide—Pruritus—Oxcarbazepine—epilepsy syndrome	3.6e-05	0.000388	CcSEcCtD
Rufinamide—Convulsion—Pregabalin—epilepsy syndrome	3.6e-05	0.000388	CcSEcCtD
Rufinamide—Hypersensitivity—Carbamazepine—epilepsy syndrome	3.6e-05	0.000388	CcSEcCtD
Rufinamide—Vision blurred—Gabapentin—epilepsy syndrome	3.59e-05	0.000387	CcSEcCtD
Rufinamide—Headache—Vigabatrin—epilepsy syndrome	3.59e-05	0.000387	CcSEcCtD
Rufinamide—Vomiting—Diazepam—epilepsy syndrome	3.59e-05	0.000387	CcSEcCtD
Rufinamide—Anorexia—Valproic Acid—epilepsy syndrome	3.58e-05	0.000386	CcSEcCtD
Rufinamide—Tremor—Gabapentin—epilepsy syndrome	3.57e-05	0.000385	CcSEcCtD
Rufinamide—Rash—Diazepam—epilepsy syndrome	3.56e-05	0.000384	CcSEcCtD
Rufinamide—Dermatitis—Diazepam—epilepsy syndrome	3.55e-05	0.000383	CcSEcCtD
Rufinamide—Dizziness—Zonisamide—epilepsy syndrome	3.53e-05	0.000381	CcSEcCtD
Rufinamide—Headache—Diazepam—epilepsy syndrome	3.53e-05	0.000381	CcSEcCtD
Rufinamide—Anxiety—Pregabalin—epilepsy syndrome	3.53e-05	0.00038	CcSEcCtD
Rufinamide—Diarrhoea—Clonazepam—epilepsy syndrome	3.52e-05	0.00038	CcSEcCtD
Rufinamide—Anaemia—Gabapentin—epilepsy syndrome	3.52e-05	0.00038	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	3.51e-05	0.000379	CcSEcCtD
Rufinamide—Asthenia—Carbamazepine—epilepsy syndrome	3.5e-05	0.000378	CcSEcCtD
Rufinamide—Agitation—Gabapentin—epilepsy syndrome	3.5e-05	0.000378	CcSEcCtD
Rufinamide—Diarrhoea—Phenytoin—epilepsy syndrome	3.5e-05	0.000378	CcSEcCtD
Rufinamide—Nausea—Fosphenytoin—epilepsy syndrome	3.49e-05	0.000377	CcSEcCtD
Rufinamide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.48e-05	0.000376	CcSEcCtD
Rufinamide—Hypersensitivity—Lamotrigine—epilepsy syndrome	3.48e-05	0.000375	CcSEcCtD
Rufinamide—Vomiting—Felbamate—epilepsy syndrome	3.47e-05	0.000374	CcSEcCtD
Rufinamide—Pruritus—Carbamazepine—epilepsy syndrome	3.46e-05	0.000373	CcSEcCtD
Rufinamide—Rash—Felbamate—epilepsy syndrome	3.44e-05	0.000371	CcSEcCtD
Rufinamide—Eye disorder—Topiramate—epilepsy syndrome	3.44e-05	0.000371	CcSEcCtD
Rufinamide—Dermatitis—Felbamate—epilepsy syndrome	3.44e-05	0.000371	CcSEcCtD
Rufinamide—Vertigo—Gabapentin—epilepsy syndrome	3.42e-05	0.000369	CcSEcCtD
Rufinamide—Headache—Felbamate—epilepsy syndrome	3.42e-05	0.000369	CcSEcCtD
Rufinamide—Cardiac disorder—Topiramate—epilepsy syndrome	3.42e-05	0.000369	CcSEcCtD
Rufinamide—Leukopenia—Gabapentin—epilepsy syndrome	3.41e-05	0.000368	CcSEcCtD
Rufinamide—Dizziness—Clonazepam—epilepsy syndrome	3.41e-05	0.000367	CcSEcCtD
Rufinamide—Nausea—Vigabatrin—epilepsy syndrome	3.4e-05	0.000367	CcSEcCtD
Rufinamide—Vomiting—Zonisamide—epilepsy syndrome	3.4e-05	0.000367	CcSEcCtD
Rufinamide—Insomnia—Valproic Acid—epilepsy syndrome	3.39e-05	0.000366	CcSEcCtD
Rufinamide—Asthenia—Lamotrigine—epilepsy syndrome	3.39e-05	0.000365	CcSEcCtD
Rufinamide—Dizziness—Phenytoin—epilepsy syndrome	3.38e-05	0.000365	CcSEcCtD
Rufinamide—Rash—Zonisamide—epilepsy syndrome	3.37e-05	0.000363	CcSEcCtD
Rufinamide—Infection—Pregabalin—epilepsy syndrome	3.37e-05	0.000363	CcSEcCtD
Rufinamide—Dermatitis—Zonisamide—epilepsy syndrome	3.37e-05	0.000363	CcSEcCtD
Rufinamide—Dizziness—Oxcarbazepine—epilepsy syndrome	3.37e-05	0.000363	CcSEcCtD
Rufinamide—Nausea—Diazepam—epilepsy syndrome	3.35e-05	0.000361	CcSEcCtD
Rufinamide—Headache—Zonisamide—epilepsy syndrome	3.35e-05	0.000361	CcSEcCtD
Rufinamide—Diarrhoea—Carbamazepine—epilepsy syndrome	3.34e-05	0.00036	CcSEcCtD
Rufinamide—Pruritus—Lamotrigine—epilepsy syndrome	3.34e-05	0.00036	CcSEcCtD
Rufinamide—Somnolence—Valproic Acid—epilepsy syndrome	3.33e-05	0.00036	CcSEcCtD
Rufinamide—Immune system disorder—Topiramate—epilepsy syndrome	3.33e-05	0.000359	CcSEcCtD
Rufinamide—Nervous system disorder—Pregabalin—epilepsy syndrome	3.33e-05	0.000359	CcSEcCtD
Rufinamide—Thrombocytopenia—Pregabalin—epilepsy syndrome	3.32e-05	0.000358	CcSEcCtD
Rufinamide—Mediastinal disorder—Topiramate—epilepsy syndrome	3.32e-05	0.000358	CcSEcCtD
Rufinamide—Dyspepsia—Valproic Acid—epilepsy syndrome	3.3e-05	0.000356	CcSEcCtD
Rufinamide—Convulsion—Gabapentin—epilepsy syndrome	3.3e-05	0.000356	CcSEcCtD
Rufinamide—Skin disorder—Pregabalin—epilepsy syndrome	3.29e-05	0.000355	CcSEcCtD
Rufinamide—Vomiting—Clonazepam—epilepsy syndrome	3.28e-05	0.000353	CcSEcCtD
Rufinamide—Decreased appetite—Valproic Acid—epilepsy syndrome	3.26e-05	0.000352	CcSEcCtD
Rufinamide—Vomiting—Phenytoin—epilepsy syndrome	3.25e-05	0.000351	CcSEcCtD
Rufinamide—Rash—Clonazepam—epilepsy syndrome	3.25e-05	0.00035	CcSEcCtD
Rufinamide—Dermatitis—Clonazepam—epilepsy syndrome	3.25e-05	0.00035	CcSEcCtD
Rufinamide—Nausea—Felbamate—epilepsy syndrome	3.24e-05	0.00035	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	3.24e-05	0.000349	CcSEcCtD
Rufinamide—Vomiting—Oxcarbazepine—epilepsy syndrome	3.24e-05	0.000349	CcSEcCtD
Rufinamide—Fatigue—Valproic Acid—epilepsy syndrome	3.23e-05	0.000349	CcSEcCtD
Rufinamide—Anxiety—Gabapentin—epilepsy syndrome	3.23e-05	0.000349	CcSEcCtD
Rufinamide—Anorexia—Pregabalin—epilepsy syndrome	3.23e-05	0.000349	CcSEcCtD
Rufinamide—Dizziness—Carbamazepine—epilepsy syndrome	3.23e-05	0.000348	CcSEcCtD
Rufinamide—Diarrhoea—Lamotrigine—epilepsy syndrome	3.23e-05	0.000348	CcSEcCtD
Rufinamide—Headache—Clonazepam—epilepsy syndrome	3.23e-05	0.000348	CcSEcCtD
Rufinamide—Rash—Phenytoin—epilepsy syndrome	3.23e-05	0.000348	CcSEcCtD
Rufinamide—Mental disorder—Topiramate—epilepsy syndrome	3.23e-05	0.000348	CcSEcCtD
Rufinamide—Dermatitis—Phenytoin—epilepsy syndrome	3.22e-05	0.000348	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	3.22e-05	0.000347	CcSEcCtD
Rufinamide—Rash—Oxcarbazepine—epilepsy syndrome	3.21e-05	0.000346	CcSEcCtD
Rufinamide—Constipation—Valproic Acid—epilepsy syndrome	3.21e-05	0.000346	CcSEcCtD
Rufinamide—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.21e-05	0.000346	CcSEcCtD
Rufinamide—Headache—Phenytoin—epilepsy syndrome	3.21e-05	0.000346	CcSEcCtD
Rufinamide—Malnutrition—Topiramate—epilepsy syndrome	3.21e-05	0.000346	CcSEcCtD
Rufinamide—Headache—Oxcarbazepine—epilepsy syndrome	3.19e-05	0.000344	CcSEcCtD
Rufinamide—Nausea—Zonisamide—epilepsy syndrome	3.18e-05	0.000342	CcSEcCtD
Rufinamide—Dizziness—Lamotrigine—epilepsy syndrome	3.12e-05	0.000337	CcSEcCtD
Rufinamide—Vomiting—Carbamazepine—epilepsy syndrome	3.11e-05	0.000335	CcSEcCtD
Rufinamide—Back pain—Topiramate—epilepsy syndrome	3.1e-05	0.000334	CcSEcCtD
Rufinamide—Infection—Gabapentin—epilepsy syndrome	3.09e-05	0.000333	CcSEcCtD
Rufinamide—Rash—Carbamazepine—epilepsy syndrome	3.08e-05	0.000332	CcSEcCtD
Rufinamide—Dermatitis—Carbamazepine—epilepsy syndrome	3.08e-05	0.000332	CcSEcCtD
Rufinamide—Insomnia—Pregabalin—epilepsy syndrome	3.07e-05	0.000331	CcSEcCtD
Rufinamide—Nausea—Clonazepam—epilepsy syndrome	3.06e-05	0.00033	CcSEcCtD
Rufinamide—Headache—Carbamazepine—epilepsy syndrome	3.06e-05	0.00033	CcSEcCtD
Rufinamide—Nervous system disorder—Gabapentin—epilepsy syndrome	3.05e-05	0.000329	CcSEcCtD
Rufinamide—Thrombocytopenia—Gabapentin—epilepsy syndrome	3.04e-05	0.000328	CcSEcCtD
Rufinamide—Nausea—Phenytoin—epilepsy syndrome	3.04e-05	0.000328	CcSEcCtD
Rufinamide—Nausea—Oxcarbazepine—epilepsy syndrome	3.02e-05	0.000326	CcSEcCtD
Rufinamide—Vision blurred—Topiramate—epilepsy syndrome	3.02e-05	0.000326	CcSEcCtD
Rufinamide—Skin disorder—Gabapentin—epilepsy syndrome	3.02e-05	0.000326	CcSEcCtD
Rufinamide—Somnolence—Pregabalin—epilepsy syndrome	3.02e-05	0.000325	CcSEcCtD
Rufinamide—Tremor—Topiramate—epilepsy syndrome	3e-05	0.000324	CcSEcCtD
Rufinamide—Vomiting—Lamotrigine—epilepsy syndrome	3e-05	0.000324	CcSEcCtD
Rufinamide—Rash—Lamotrigine—epilepsy syndrome	2.98e-05	0.000321	CcSEcCtD
Rufinamide—Dermatitis—Lamotrigine—epilepsy syndrome	2.97e-05	0.000321	CcSEcCtD
Rufinamide—Anorexia—Gabapentin—epilepsy syndrome	2.96e-05	0.00032	CcSEcCtD
Rufinamide—Anaemia—Topiramate—epilepsy syndrome	2.96e-05	0.00032	CcSEcCtD
Rufinamide—Headache—Lamotrigine—epilepsy syndrome	2.96e-05	0.000319	CcSEcCtD
Rufinamide—Decreased appetite—Pregabalin—epilepsy syndrome	2.95e-05	0.000318	CcSEcCtD
Rufinamide—Agitation—Topiramate—epilepsy syndrome	2.95e-05	0.000318	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.93e-05	0.000316	CcSEcCtD
Rufinamide—Fatigue—Pregabalin—epilepsy syndrome	2.92e-05	0.000315	CcSEcCtD
Rufinamide—Nausea—Carbamazepine—epilepsy syndrome	2.9e-05	0.000313	CcSEcCtD
Rufinamide—Constipation—Pregabalin—epilepsy syndrome	2.9e-05	0.000313	CcSEcCtD
Rufinamide—Vertigo—Topiramate—epilepsy syndrome	2.88e-05	0.000311	CcSEcCtD
Rufinamide—Leukopenia—Topiramate—epilepsy syndrome	2.87e-05	0.000309	CcSEcCtD
Rufinamide—Insomnia—Gabapentin—epilepsy syndrome	2.81e-05	0.000303	CcSEcCtD
Rufinamide—Nausea—Lamotrigine—epilepsy syndrome	2.8e-05	0.000302	CcSEcCtD
Rufinamide—Convulsion—Topiramate—epilepsy syndrome	2.78e-05	0.0003	CcSEcCtD
Rufinamide—Somnolence—Gabapentin—epilepsy syndrome	2.76e-05	0.000298	CcSEcCtD
Rufinamide—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.76e-05	0.000298	CcSEcCtD
Rufinamide—Dyspepsia—Gabapentin—epilepsy syndrome	2.74e-05	0.000295	CcSEcCtD
Rufinamide—Anxiety—Topiramate—epilepsy syndrome	2.72e-05	0.000293	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2.71e-05	0.000292	CcSEcCtD
Rufinamide—Decreased appetite—Gabapentin—epilepsy syndrome	2.7e-05	0.000292	CcSEcCtD
Rufinamide—Asthenia—Valproic Acid—epilepsy syndrome	2.69e-05	0.00029	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.68e-05	0.00029	CcSEcCtD
Rufinamide—Fatigue—Gabapentin—epilepsy syndrome	2.68e-05	0.000289	CcSEcCtD
Rufinamide—Constipation—Gabapentin—epilepsy syndrome	2.66e-05	0.000287	CcSEcCtD
Rufinamide—Pruritus—Valproic Acid—epilepsy syndrome	2.65e-05	0.000286	CcSEcCtD
Rufinamide—Infection—Topiramate—epilepsy syndrome	2.6e-05	0.00028	CcSEcCtD
Rufinamide—Diarrhoea—Valproic Acid—epilepsy syndrome	2.57e-05	0.000277	CcSEcCtD
Rufinamide—Nervous system disorder—Topiramate—epilepsy syndrome	2.57e-05	0.000277	CcSEcCtD
Rufinamide—Thrombocytopenia—Topiramate—epilepsy syndrome	2.56e-05	0.000276	CcSEcCtD
Rufinamide—Skin disorder—Topiramate—epilepsy syndrome	2.54e-05	0.000274	CcSEcCtD
Rufinamide—Hypersensitivity—Pregabalin—epilepsy syndrome	2.5e-05	0.000269	CcSEcCtD
Rufinamide—Anorexia—Topiramate—epilepsy syndrome	2.49e-05	0.000269	CcSEcCtD
Rufinamide—Dizziness—Valproic Acid—epilepsy syndrome	2.48e-05	0.000268	CcSEcCtD
Rufinamide—Asthenia—Pregabalin—epilepsy syndrome	2.43e-05	0.000262	CcSEcCtD
Rufinamide—Pruritus—Pregabalin—epilepsy syndrome	2.4e-05	0.000259	CcSEcCtD
Rufinamide—Vomiting—Valproic Acid—epilepsy syndrome	2.39e-05	0.000257	CcSEcCtD
Rufinamide—Insomnia—Topiramate—epilepsy syndrome	2.37e-05	0.000255	CcSEcCtD
Rufinamide—Rash—Valproic Acid—epilepsy syndrome	2.37e-05	0.000255	CcSEcCtD
Rufinamide—Dermatitis—Valproic Acid—epilepsy syndrome	2.36e-05	0.000255	CcSEcCtD
Rufinamide—Headache—Valproic Acid—epilepsy syndrome	2.35e-05	0.000253	CcSEcCtD
Rufinamide—Somnolence—Topiramate—epilepsy syndrome	2.33e-05	0.000251	CcSEcCtD
Rufinamide—Diarrhoea—Pregabalin—epilepsy syndrome	2.32e-05	0.00025	CcSEcCtD
Rufinamide—Dyspepsia—Topiramate—epilepsy syndrome	2.3e-05	0.000248	CcSEcCtD
Rufinamide—Hypersensitivity—Gabapentin—epilepsy syndrome	2.29e-05	0.000247	CcSEcCtD
Rufinamide—Decreased appetite—Topiramate—epilepsy syndrome	2.27e-05	0.000245	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.26e-05	0.000244	CcSEcCtD
Rufinamide—Fatigue—Topiramate—epilepsy syndrome	2.26e-05	0.000243	CcSEcCtD
Rufinamide—Dizziness—Pregabalin—epilepsy syndrome	2.24e-05	0.000242	CcSEcCtD
Rufinamide—Constipation—Topiramate—epilepsy syndrome	2.24e-05	0.000241	CcSEcCtD
Rufinamide—Asthenia—Gabapentin—epilepsy syndrome	2.23e-05	0.000241	CcSEcCtD
Rufinamide—Nausea—Valproic Acid—epilepsy syndrome	2.23e-05	0.00024	CcSEcCtD
Rufinamide—Pruritus—Gabapentin—epilepsy syndrome	2.2e-05	0.000237	CcSEcCtD
Rufinamide—Vomiting—Pregabalin—epilepsy syndrome	2.16e-05	0.000233	CcSEcCtD
Rufinamide—Rash—Pregabalin—epilepsy syndrome	2.14e-05	0.000231	CcSEcCtD
Rufinamide—Dermatitis—Pregabalin—epilepsy syndrome	2.14e-05	0.00023	CcSEcCtD
Rufinamide—Diarrhoea—Gabapentin—epilepsy syndrome	2.13e-05	0.000229	CcSEcCtD
Rufinamide—Headache—Pregabalin—epilepsy syndrome	2.12e-05	0.000229	CcSEcCtD
Rufinamide—Dizziness—Gabapentin—epilepsy syndrome	2.06e-05	0.000222	CcSEcCtD
Rufinamide—Nausea—Pregabalin—epilepsy syndrome	2.01e-05	0.000217	CcSEcCtD
Rufinamide—Vomiting—Gabapentin—epilepsy syndrome	1.98e-05	0.000213	CcSEcCtD
Rufinamide—Rash—Gabapentin—epilepsy syndrome	1.96e-05	0.000211	CcSEcCtD
Rufinamide—Dermatitis—Gabapentin—epilepsy syndrome	1.96e-05	0.000211	CcSEcCtD
Rufinamide—Headache—Gabapentin—epilepsy syndrome	1.95e-05	0.00021	CcSEcCtD
Rufinamide—Hypersensitivity—Topiramate—epilepsy syndrome	1.93e-05	0.000208	CcSEcCtD
Rufinamide—Asthenia—Topiramate—epilepsy syndrome	1.88e-05	0.000202	CcSEcCtD
Rufinamide—Pruritus—Topiramate—epilepsy syndrome	1.85e-05	0.0002	CcSEcCtD
Rufinamide—Nausea—Gabapentin—epilepsy syndrome	1.85e-05	0.000199	CcSEcCtD
Rufinamide—Diarrhoea—Topiramate—epilepsy syndrome	1.79e-05	0.000193	CcSEcCtD
Rufinamide—Dizziness—Topiramate—epilepsy syndrome	1.73e-05	0.000187	CcSEcCtD
Rufinamide—Vomiting—Topiramate—epilepsy syndrome	1.66e-05	0.000179	CcSEcCtD
Rufinamide—Rash—Topiramate—epilepsy syndrome	1.65e-05	0.000178	CcSEcCtD
Rufinamide—Dermatitis—Topiramate—epilepsy syndrome	1.65e-05	0.000178	CcSEcCtD
Rufinamide—Headache—Topiramate—epilepsy syndrome	1.64e-05	0.000177	CcSEcCtD
Rufinamide—Nausea—Topiramate—epilepsy syndrome	1.55e-05	0.000168	CcSEcCtD
Rufinamide—ALB—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	3.41e-06	4.37e-05	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—MMP9—epilepsy syndrome	3.39e-06	4.34e-05	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—AKT1—epilepsy syndrome	3.37e-06	4.32e-05	CbGpPWpGaD
Rufinamide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—epilepsy syndrome	3.35e-06	4.29e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	3.34e-06	4.28e-05	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—VEGFA—epilepsy syndrome	3.33e-06	4.27e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—COX3—epilepsy syndrome	3.33e-06	4.26e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—YWHAZ—epilepsy syndrome	3.3e-06	4.22e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	3.29e-06	4.22e-05	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—SRC—epilepsy syndrome	3.29e-06	4.21e-05	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—SRC—epilepsy syndrome	3.29e-06	4.21e-05	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	3.28e-06	4.2e-05	CbGpPWpGaD
Rufinamide—ALB—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	3.28e-06	4.2e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NHLRC1—epilepsy syndrome	3.27e-06	4.19e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PNPO—epilepsy syndrome	3.27e-06	4.19e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—EPM2A—epilepsy syndrome	3.27e-06	4.19e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GAMT—epilepsy syndrome	3.27e-06	4.19e-05	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—VEGFA—epilepsy syndrome	3.2e-06	4.1e-05	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—VEGFA—epilepsy syndrome	3.2e-06	4.1e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PPIA—epilepsy syndrome	3.19e-06	4.08e-05	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—SRC—epilepsy syndrome	3.17e-06	4.06e-05	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—SRC—epilepsy syndrome	3.17e-06	4.06e-05	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	3.17e-06	4.06e-05	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	3.17e-06	4.06e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PFKL—epilepsy syndrome	3.15e-06	4.04e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—KCNB1—epilepsy syndrome	3.15e-06	4.04e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CACNA2D2—epilepsy syndrome	3.15e-06	4.04e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SLCO1A2—epilepsy syndrome	3.15e-06	4.04e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SLC6A8—epilepsy syndrome	3.15e-06	4.04e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—POMC—epilepsy syndrome	3.14e-06	4.02e-05	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—SRC—epilepsy syndrome	3.12e-06	4e-05	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—VEGFA—epilepsy syndrome	3.09e-06	3.95e-05	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—VEGFA—epilepsy syndrome	3.09e-06	3.95e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	3.08e-06	3.94e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CCL2—epilepsy syndrome	3.07e-06	3.93e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—FGF2—epilepsy syndrome	3.06e-06	3.91e-05	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—VEGFA—epilepsy syndrome	3.04e-06	3.9e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CA4—epilepsy syndrome	3.04e-06	3.89e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—QDPR—epilepsy syndrome	3.04e-06	3.89e-05	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	3.04e-06	3.89e-05	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—AKT1—epilepsy syndrome	3.01e-06	3.85e-05	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—TNF—epilepsy syndrome	2.99e-06	3.82e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—ATP2A2—epilepsy syndrome	2.91e-06	3.73e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NEU1—epilepsy syndrome	2.88e-06	3.69e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—UPB1—epilepsy syndrome	2.88e-06	3.69e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ATIC—epilepsy syndrome	2.88e-06	3.69e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—COX3—epilepsy syndrome	2.86e-06	3.66e-05	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—TNF—epilepsy syndrome	2.86e-06	3.66e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—RELA—epilepsy syndrome	2.84e-06	3.63e-05	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	2.83e-06	3.62e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—ITGA2—epilepsy syndrome	2.82e-06	3.61e-05	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—TNF—epilepsy syndrome	2.79e-06	3.57e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—HSD17B4—epilepsy syndrome	2.78e-06	3.55e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—FGF2—epilepsy syndrome	2.78e-06	3.55e-05	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—AKT1—epilepsy syndrome	2.75e-06	3.52e-05	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—TNF—epilepsy syndrome	2.75e-06	3.51e-05	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—TNF—epilepsy syndrome	2.75e-06	3.51e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—PRKCB—epilepsy syndrome	2.72e-06	3.49e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—KCNB1—epilepsy syndrome	2.71e-06	3.47e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CACNA2D2—epilepsy syndrome	2.71e-06	3.47e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PFKL—epilepsy syndrome	2.71e-06	3.47e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SLCO1A2—epilepsy syndrome	2.71e-06	3.47e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SLC6A8—epilepsy syndrome	2.71e-06	3.47e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GBE1—epilepsy syndrome	2.68e-06	3.43e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PPP1R3C—epilepsy syndrome	2.68e-06	3.43e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	2.65e-06	3.39e-05	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—TNF—epilepsy syndrome	2.65e-06	3.39e-05	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—TNF—epilepsy syndrome	2.65e-06	3.39e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	2.63e-06	3.37e-05	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	2.59e-06	3.31e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—RELA—epilepsy syndrome	2.58e-06	3.3e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CA13—epilepsy syndrome	2.55e-06	3.26e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MTOR—epilepsy syndrome	2.53e-06	3.24e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ASAH1—epilepsy syndrome	2.52e-06	3.23e-05	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	2.52e-06	3.22e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—ADRA2A—epilepsy syndrome	2.48e-06	3.18e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ATIC—epilepsy syndrome	2.48e-06	3.17e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—UPB1—epilepsy syndrome	2.48e-06	3.17e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NEU1—epilepsy syndrome	2.48e-06	3.17e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PLAT—epilepsy syndrome	2.47e-06	3.17e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—STXBP1—epilepsy syndrome	2.45e-06	3.14e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—MMP9—epilepsy syndrome	2.42e-06	3.1e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NT5E—epilepsy syndrome	2.39e-06	3.06e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ALAD—epilepsy syndrome	2.39e-06	3.06e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—HSD17B4—epilepsy syndrome	2.39e-06	3.05e-05	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—AKT1—epilepsy syndrome	2.35e-06	3e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—NOS1—epilepsy syndrome	2.33e-06	2.98e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CASP3—epilepsy syndrome	2.32e-06	2.98e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GBE1—epilepsy syndrome	2.3e-06	2.95e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PPP1R3C—epilepsy syndrome	2.3e-06	2.95e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ALDH7A1—epilepsy syndrome	2.28e-06	2.92e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CACNA1A—epilepsy syndrome	2.28e-06	2.92e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—JUN—epilepsy syndrome	2.26e-06	2.89e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	2.25e-06	2.88e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ST3GAL3—epilepsy syndrome	2.23e-06	2.86e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—SRC—epilepsy syndrome	2.23e-06	2.85e-05	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—AKT1—epilepsy syndrome	2.22e-06	2.85e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MMP9—epilepsy syndrome	2.2e-06	2.81e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ADSL—epilepsy syndrome	2.19e-06	2.8e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—AKT3—epilepsy syndrome	2.18e-06	2.79e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—VEGFA—epilepsy syndrome	2.17e-06	2.78e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ASAH1—epilepsy syndrome	2.17e-06	2.77e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PLAUR—epilepsy syndrome	2.15e-06	2.76e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GLUL—epilepsy syndrome	2.14e-06	2.74e-05	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	2.14e-06	2.74e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—AKT1—epilepsy syndrome	2.13e-06	2.73e-05	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—AKT1—epilepsy syndrome	2.13e-06	2.72e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—STXBP1—epilepsy syndrome	2.11e-06	2.7e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CACNA1D—epilepsy syndrome	2.1e-06	2.69e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NT5E—epilepsy syndrome	2.05e-06	2.63e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ALAD—epilepsy syndrome	2.05e-06	2.63e-05	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—AKT1—epilepsy syndrome	2.04e-06	2.62e-05	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—AKT1—epilepsy syndrome	2.04e-06	2.62e-05	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	2.04e-06	2.62e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—SRC—epilepsy syndrome	2.03e-06	2.59e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—CDC42—epilepsy syndrome	1.99e-06	2.54e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—VEGFA—epilepsy syndrome	1.97e-06	2.53e-05	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—AKT1—epilepsy syndrome	1.97e-06	2.52e-05	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—AKT1—epilepsy syndrome	1.97e-06	2.52e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—TXNRD1—epilepsy syndrome	1.97e-06	2.52e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CACNA1A—epilepsy syndrome	1.96e-06	2.51e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ALDH7A1—epilepsy syndrome	1.96e-06	2.51e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ADK—epilepsy syndrome	1.93e-06	2.47e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PDXK—epilepsy syndrome	1.93e-06	2.47e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	1.93e-06	2.47e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—FAR1—epilepsy syndrome	1.93e-06	2.47e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	1.93e-06	2.47e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CERS1—epilepsy syndrome	1.93e-06	2.47e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ST3GAL3—epilepsy syndrome	1.92e-06	2.45e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—AQP1—epilepsy syndrome	1.91e-06	2.45e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ADSL—epilepsy syndrome	1.88e-06	2.41e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—TNF—epilepsy syndrome	1.86e-06	2.38e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GLUL—epilepsy syndrome	1.84e-06	2.36e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CACNA1D—epilepsy syndrome	1.81e-06	2.32e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—FYN—epilepsy syndrome	1.77e-06	2.26e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	1.77e-06	2.26e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GAMT—epilepsy syndrome	1.77e-06	2.26e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	1.77e-06	2.26e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PNPO—epilepsy syndrome	1.77e-06	2.26e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—KCNJ11—epilepsy syndrome	1.73e-06	2.21e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CHRM3—epilepsy syndrome	1.73e-06	2.21e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—YWHAZ—epilepsy syndrome	1.7e-06	2.18e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—TXNRD1—epilepsy syndrome	1.69e-06	2.17e-05	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.68e-06	2.15e-05	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.67e-06	2.13e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—AQP1—epilepsy syndrome	1.64e-06	2.1e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—QDPR—epilepsy syndrome	1.64e-06	2.1e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CA4—epilepsy syndrome	1.64e-06	2.1e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	1.64e-06	2.09e-05	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.61e-06	2.07e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	1.6e-06	2.05e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.58e-06	2.02e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	1.56e-06	2e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.54e-06	1.98e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PLAU—epilepsy syndrome	1.51e-06	1.93e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CHRM3—epilepsy syndrome	1.49e-06	1.9e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—KCNJ11—epilepsy syndrome	1.49e-06	1.9e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.46e-06	1.87e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.46e-06	1.87e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.46e-06	1.87e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.46e-06	1.87e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.46e-06	1.87e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ABCG2—epilepsy syndrome	1.41e-06	1.8e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PRKCB—epilepsy syndrome	1.4e-06	1.8e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—NOS2—epilepsy syndrome	1.39e-06	1.78e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—AKT1—epilepsy syndrome	1.39e-06	1.77e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.38e-06	1.77e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP2C19—epilepsy syndrome	1.37e-06	1.76e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP11A1—epilepsy syndrome	1.36e-06	1.75e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.36e-06	1.73e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—UPB1—epilepsy syndrome	1.34e-06	1.71e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ATIC—epilepsy syndrome	1.34e-06	1.71e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NEU1—epilepsy syndrome	1.34e-06	1.71e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	1.29e-06	1.65e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—AKT1—epilepsy syndrome	1.26e-06	1.61e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	1.24e-06	1.59e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GBE1—epilepsy syndrome	1.24e-06	1.59e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP2D6—epilepsy syndrome	1.23e-06	1.58e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ABCG2—epilepsy syndrome	1.21e-06	1.55e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP2C19—epilepsy syndrome	1.18e-06	1.51e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP11A1—epilepsy syndrome	1.17e-06	1.5e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ADRA2A—epilepsy syndrome	1.17e-06	1.5e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	1.17e-06	1.5e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—BCHE—epilepsy syndrome	1.17e-06	1.49e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.16e-06	1.49e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	1.14e-06	1.46e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SLC2A1—epilepsy syndrome	1.11e-06	1.43e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NT5E—epilepsy syndrome	1.11e-06	1.42e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ALAD—epilepsy syndrome	1.11e-06	1.42e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PLCB1—epilepsy syndrome	1.1e-06	1.41e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—TH—epilepsy syndrome	1.1e-06	1.4e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP2D6—epilepsy syndrome	1.06e-06	1.35e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	1.06e-06	1.35e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	1.06e-06	1.35e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.04e-06	1.33e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.01e-06	1.3e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ADRA2A—epilepsy syndrome	1.01e-06	1.29e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—BCHE—epilepsy syndrome	1e-06	1.28e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GLUL—epilepsy syndrome	9.95e-07	1.27e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	9.95e-07	1.27e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	9.76e-07	1.25e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SLC2A1—epilepsy syndrome	9.57e-07	1.23e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PLCB1—epilepsy syndrome	9.47e-07	1.21e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—TH—epilepsy syndrome	9.43e-07	1.21e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	9.29e-07	1.19e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—HMOX1—epilepsy syndrome	9.16e-07	1.17e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	9.13e-07	1.17e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CAT—epilepsy syndrome	9.04e-07	1.16e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—AQP1—epilepsy syndrome	8.87e-07	1.13e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ABCB1—epilepsy syndrome	8.79e-07	1.13e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—SRC—epilepsy syndrome	8.25e-07	1.06e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GPX1—epilepsy syndrome	8.17e-07	1.05e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—VEGFA—epilepsy syndrome	8.03e-07	1.03e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	8.02e-07	1.03e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	8.02e-07	1.03e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—HMOX1—epilepsy syndrome	7.87e-07	1.01e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CAT—epilepsy syndrome	7.77e-07	9.94e-06	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ABCB1—epilepsy syndrome	7.56e-07	9.67e-06	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—AGT—epilepsy syndrome	7.17e-07	9.17e-06	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GPX1—epilepsy syndrome	7.02e-07	8.99e-06	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—APOE—epilepsy syndrome	7.02e-07	8.99e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	6.54e-07	8.37e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	6.37e-07	8.15e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	6.33e-07	8.1e-06	CbGpPWpGaD
Rufinamide—ALB—Metabolism—AGT—epilepsy syndrome	6.16e-07	7.88e-06	CbGpPWpGaD
Rufinamide—ALB—Metabolism—APOE—epilepsy syndrome	6.04e-07	7.73e-06	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—POMC—epilepsy syndrome	6.03e-07	7.72e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	5.71e-07	7.31e-06	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ALB—epilepsy syndrome	5.5e-07	7.04e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	5.44e-07	6.96e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—BCHE—epilepsy syndrome	5.42e-07	6.93e-06	CbGpPWpGaD
Rufinamide—ALB—Metabolism—POMC—epilepsy syndrome	5.18e-07	6.64e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	5.17e-07	6.61e-06	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—AKT1—epilepsy syndrome	5.13e-07	6.56e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	5.11e-07	6.54e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—TH—epilepsy syndrome	5.09e-07	6.52e-06	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PTGS2—epilepsy syndrome	4.81e-07	6.16e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	4.25e-07	5.44e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CAT—epilepsy syndrome	4.19e-07	5.37e-06	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PTGS2—epilepsy syndrome	4.14e-07	5.29e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	4.08e-07	5.22e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GPX1—epilepsy syndrome	3.79e-07	4.85e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—AGT—epilepsy syndrome	3.33e-07	4.26e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—APOE—epilepsy syndrome	3.26e-07	4.17e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—POMC—epilepsy syndrome	2.8e-07	3.58e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ALB—epilepsy syndrome	2.55e-07	3.27e-06	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—AKT1—epilepsy syndrome	2.42e-07	3.1e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	2.23e-07	2.86e-06	CbGpPWpGaD
Rufinamide—ALB—Metabolism—AKT1—epilepsy syndrome	2.08e-07	2.66e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.12e-07	1.44e-06	CbGpPWpGaD
